Formulation and development of paediatric orally disintegrating carbamazepine tablets

por Canadell-Heredia, R, Suñé-Pou, M, Nardi-Ricart, A, Pérez-Lozano, P, Suñé-Negre, JM, García-Montoya, E
Publicado 2022

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone

por Wasan, H S, Springett, G M, Chodkiewicz, C, Wong, R, Maurel, J, Barone, C, Rosbrook, B, Ricart, A D, Kim, S, Spano, J-P
Publicado 2009

The effect of a multi-target protocol on cetacean detection and abundance estimation in aerial surveys

por Lambert, C., Authier, M., Dorémus, G., Gilles, A., Hammond, P., Laran, S., Ricart, A., Ridoux, V., Scheidat, M., Spitz, J., Van Canneyt, O.
Publicado 2019

Improvement of the Pour Plate Method by Separate Sterilization of Agar and Other Medium Components and Reduction of the Agar Concentration

por Terrones-Fernandez, I., Casino, P., López, A., Peiró, S., Ríos, S., Nardi-Ricart, A., García-Montoya, E., Asensio, D., Marqués, A. M., Castilla, R., Gamez-Montero, P. J., Piqué, N.
Publicado 2023

Erlotinib ‘dosing-to-rash’: a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer

por Mita, A C, Papadopoulos, K, de Jonge, M J A, Schwartz, G, Verweij, J, Mita, M M, Ricart, A, Chu, Q S-C, Tolcher, A W, Wood, L, McCarthy, S, Hamilton, M, Iwata, K, Wacker, B, Witt, K, Rowinsky, E K
Publicado 2011